Literature DB >> 12477852

Specificity of plasma membrane targeting by the rous sarcoma virus gag protein.

Lisa Z Scheifele1, Jonathan D Rhoads, Leslie J Parent.   

Abstract

Budding of C-type retroviruses begins when the viral Gag polyprotein is directed to the plasma membrane by an N-terminal membrane-binding (M) domain. While dispersed basic amino acids within the M domain are critical for stable membrane association and consequent particle assembly, additional residues or motifs may be required for specific plasma membrane targeting and binding. We have identified an assembly-defective Rous sarcoma virus (RSV) Gag mutant that retains significant membrane affinity despite having a deletion of the fourth alpha-helix of the M domain. Examination of the mutant protein's subcellular distribution revealed that it was not localized to the plasma membrane but instead was mistargeted to intracytoplasmic membranes. Specific plasma membrane targeting was restored by the addition of myristate plus a single basic residue, by multiple basic residues, or by the heterologous hydrophobic membrane-binding domain from the cellular Fyn protein. These results suggest that the fourth alpha-helix of the RSV M domain promotes specific targeting of Gag to the plasma membrane, either through a direct interaction with plasma membrane phospholipids or a membrane-associated cellular factor or by maintaining the conformation of Gag to expose specific plasma membrane targeting sequences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477852      PMCID: PMC140635          DOI: 10.1128/jvi.77.1.470-480.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Functional roles for fatty acylated amino-terminal domains in subcellular localization.

Authors:  J B McCabe; L G Berthiaume
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  Ubiquitin is part of the retrovirus budding machinery.

Authors:  A Patnaik; V Chau; J W Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  Targeting proteins to plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation.

Authors:  W van't Hof; M D Resh
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

4.  Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.

Authors:  D H Nguyen; J E Hildreth
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.

Authors:  A Ono; J M Orenstein; E O Freed
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway.

Authors:  A Apolloni; I A Prior; M Lindsay; R G Parton; J F Hancock
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

9.  Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions.

Authors:  P Provitera; F Bouamr; D Murray; C Carter; S Scarlata
Journal:  J Mol Biol       Date:  2000-02-25       Impact factor: 5.469

10.  Repositioning basic residues in the M domain of the Rous sarcoma virus gag protein.

Authors:  E M Callahan; J W Wills
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

View more
  8 in total

1.  Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.

Authors:  Jany Chan; Robert A Dick; Volker M Vogt
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

2.  Insertion of a classical nuclear import signal into the matrix domain of the Rous sarcoma virus Gag protein interferes with virus replication.

Authors:  Rachel A Garbitt; Karen R Bone; Leslie J Parent
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  ALV-miRNA-p19-01 Promotes Viral Replication via Targeting Dual Specificity Phosphatase 6.

Authors:  Yiming Yan; Sheng Chen; Liqin Liao; Shuang Gao; Yanling Pang; Xinheng Zhang; Huanmin Zhang; Qingmei Xie
Journal:  Viruses       Date:  2022-04-13       Impact factor: 5.818

4.  Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.

Authors:  Akira Ono; Eric O Freed
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2.

Authors:  Kang Chen; Indra Bachtiar; Grzegorz Piszczek; Fadila Bouamr; Carol Carter; Nico Tjandra
Journal:  Biochemistry       Date:  2008-01-26       Impact factor: 3.162

6.  Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting.

Authors:  Gisselle Medina; Andrew Pincetic; Lorna S Ehrlich; Yongjun Zhang; Yi Tang; Jonathan Leis; Carol A Carter
Journal:  Virology       Date:  2008-07-20       Impact factor: 3.616

7.  Functional Equivalence of Retroviral MA Domains in Facilitating Psi RNA Binding Specificity by Gag.

Authors:  Tiffiny Rye-McCurdy; Erik D Olson; Shuohui Liu; Christiana Binkley; Joshua-Paolo Reyes; Brian R Thompson; John M Flanagan; Leslie J Parent; Karin Musier-Forsyth
Journal:  Viruses       Date:  2016-09-19       Impact factor: 5.048

8.  RNA-Binding Domains of Heterologous Viral Proteins Substituted for Basic Residues in the RSV Gag NC Domain Restore Specific Packaging of Genomic RNA.

Authors:  Breanna L Rice; Timothy L Lochmann; Leslie J Parent
Journal:  Viruses       Date:  2020-03-27       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.